Browsing by Author/Contributor "Lane, Stephanie R., 1982-"

Now showing items 1-8 of 8

  • 99mTc-DPR-SSS-BBN for diagnosis of human cancers [abstract] 

    Heinzke, Laura; Retzloff, Lauren Brooke, 1980-; Lane, Stephanie R., 1982-; Prasanphanich, Adam; Sieckman, Gary; Rold, Tammy L.; Hoffman, Timothy Joseph, 1958-; Smith, Charles J. (Charles Jeffrey), 1969- (University of Missouri--Columbia. Office of Undergraduate Research, 2008)
    Receptor-specific, radiolabeled peptides have become increasingly popular as targeting vectors for the development of new diagnostic radiopharmaceuticals. The over-expression of certain receptors such as the gastrin releasing ...

  • In vitro/in vivo assessment of novel 99mTc-bombesin conjugates in human cancer tissue [abstract] 

    Heinzke, Laura; Prasanphanich, Adam; Lane, Stephanie R., 1982-; Retzloff, Lauren Brooke, 1980-; Rold, Tammy L.; Sieckman, Gary; Hoffman, Timothy Joseph, 1958-; Smith, Charles J. (Charles Jeffrey), 1969- (University of Missouri--Columbia. Office of Undergraduate Research, 2007)
    Receptor-specific, radiolabeled peptides are becoming increasingly popular as targeting vectors for the development of new diagnostic radiopharmaceuticals. The over-expression of certain receptors such as the gastrin ...

  • In vivo and in vitro evaluation of 64 CU-labeled bombesin analogs for targeting gastrin-releasing peptide receptors on human prostate cancer [abstract] 

    Lane, Stephanie R., 1982- (2010-03)
    Introduction: Gastrin-releasing peptide receptors (GRPr) are expressed in high numbers on human prostate cancer. The bombesin peptide derivative, BBN(7- 14)NH2, has high affinity and selectivity to GRPr. Therefore, Copper-64 ...

  • Prospective radiolabled bombesin conjugates for prostate cancer imaging and therapeutic agents 

    Lane, Stephanie R., 1982- (University of Missouri--Columbia, 2009)
    An active area of prostate cancer research is in the synthesis of radiolabeled peptides for in vivo tumor imaging or therapy. This method is possible since specific receptors are expressed in high concentration on certain ...

  • Radioactive materials: Winning the battle against cancer [abstract] 

    Lane, Stephanie R., 1982- (University of Missouri--Columbia. Office of Undergraduate Research, 2004)
    Radiopharmaceuticals are drugs containing a radioactive atom that can be used for the treatment of certain cancers. The radiopharmaceuticals we are interested in consist of a radioactive source contained in a molecular ...

  • Reduction of rhenium (V) oxo Schiff Base Complexes with triphenyl phosphine ligands 

    Sisay, Nebiat; Williams, Stephen A.; Lane, Stephanie R., 1982-; Jurisson, Silvia S. (Silvia Sabine) (University of Missouri--Columbia. Office of Undergraduate Research, 2005)
    One approach to the treatment of cancer is to direct beta-emitting radionuclide to the cancer site where the radiation destroys the cancer cells. This can be achieved by coordinating the radioisotope in a very stable ...

  • Reduction of rheniumV oxo Schiff base complexes with triethylphosphine 

    Williams, Stephen A.; Lane, Stephanie R., 1982-; Sisay, Nebiat; Jurisson, Silvia S. (Silvia Sabine) (University of Missouri--Columbia. Office of Undergraduate Research, 2005)
    Pioneering techniques for therapeutic treatment of cancers involve targeting cancer sites with strong beta-emitting radionuclides, thereby destroying the cancer cells. This is achieved by coordinating the radioisotope to ...

  • Reducution of rhenium(V)-oxo schiff base complexesith triphenyl phosphine ligands [abstract] 

    Sisay, Nebiat; Lane, Stephanie R., 1982-; Jurisson, Silvia S. (Silvia Sabine) (University of Missouri--Columbia. Office of Undergraduate Research, 2006)
    The purpose of this research is to produce radiopharmaceutical drugs for the possible use in therapy and diagnosis of cancer. A radiopharmaceutical drug is composed of a radioactive element contained within chelating agent ...